CRISPR Therapeutics

CRISPR Therapeutics

Gene-editing biotech developing transformative treatments for haematological disorders, oncology, and diabetes using CRISPR-Cas9 technology.

Industries Biotechnology and Digital Health

Regions Europe North America

Tags crispr gene-editing gene-therapy haematology

HeadquartersZug, Switzerland

Founded2013

FounderEmmanuelle Charpentier

Employees200–499

StockCRSP

OwnershipPublic

Geographic PresenceEurope|North America

HiringHiring

Innovation LevelHigh

Commercialisation StageCommercialized

Africa PresenceYes

Websitewww.crisprtx.com